MedPath

Nitroglycerin

Generic Name
Nitroglycerin
Brand Names
Gonitro, Minitran, Mylan-nitro, Nitro-bid, Nitro-dur, Nitroject, Nitrolingual, Nitromist, Nitrostat, Rectiv, Trinipatch
Drug Type
Small Molecule
Chemical Formula
C3H5N3O9
CAS Number
55-63-0
Unique Ingredient Identifier
G59M7S0WS3

Overview

Nitroglycerin, also known as glyceryl trinitrate, is an organic nitrate and a vasodilating agent that was first discovered in 1847. Originally used to dynamite, its antianginal effects were identified in the late 1860s after it produced headaches in factory workers while workers with angina pectoris or heart failure experienced relief from chest pain. Its use as a treatment for angina dates back to 1879 and is still used to treat and prevent angina. Nitroglycerin causes vasodilation in both arteries and veins. Nitroglycerin is used in a variety of different conditions, including angina pectoris due to coronary artery disease, peri-operative hypertension, congestive heart failure, and chronic anal fissure. It is also used to induce intraoperative hypotension.

Background

Nitroglycerin, also known as glyceryl trinitrate, is an organic nitrate and a vasodilating agent that was first discovered in 1847. Originally used to dynamite, its antianginal effects were identified in the late 1860s after it produced headaches in factory workers while workers with angina pectoris or heart failure experienced relief from chest pain. Its use as a treatment for angina dates back to 1879 and is still used to treat and prevent angina. Nitroglycerin causes vasodilation in both arteries and veins. Nitroglycerin is used in a variety of different conditions, including angina pectoris due to coronary artery disease, peri-operative hypertension, congestive heart failure, and chronic anal fissure. It is also used to induce intraoperative hypotension.

Indication

Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension. Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.

Associated Conditions

  • Angina Attacks
  • Angina Pectoris
  • Congestive Heart Failure (CHF)
  • Perioperative Hypertension
  • Moderate to severe pain

FDA Approved Products

Nitroglycerin Transdermal System
Manufacturer:Zydus Pharmaceuticals USA Inc.
Route:TRANSDERMAL
Strength:0.4 mg in 1 h
Approved: 2022/10/20
NDC:68382-310
nitroglycerin
Manufacturer:Lifestar Pharma LLC
Route:SUBLINGUAL
Strength:0.6 mg in 1 1
Approved: 2023/12/05
NDC:70756-016
nitroglycerin
Manufacturer:A-S Medication Solutions
Route:SUBLINGUAL
Strength:0.4 mg in 1 1
Approved: 2018/01/30
NDC:50090-4874
nitroglycerin
Manufacturer:Bryant Ranch Prepack
Route:SUBLINGUAL
Strength:0.4 mg in 1 1
Approved: 2023/03/15
NDC:63629-8829
GONITRO
Manufacturer:Espero Pharmaceuticals, Inc.
Route:SUBLINGUAL
Strength:400 ug in 1 1
Approved: 2016/06/30
NDC:70007-400

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath